Dealing with biotech manufacturing delays is tough. How can you keep stakeholders informed and engaged?

由人工智能和领英社区提供技术支持

In biotechnology, manufacturing delays can be a significant hurdle. Unlike other industries, biotech products often involve complex biological processes that can be unpredictable. This uncertainty can lead to delays that are not only frustrating but can also impact clinical trials, product launches, and overall business timelines. It's essential to maintain open lines of communication with stakeholders, including investors, partners, and regulatory bodies, to manage expectations and maintain trust. Transparency is key in these situations, and keeping everyone informed about the reasons for delays, the steps being taken to address them, and the revised timelines can help mitigate the negative impact of these setbacks.

此文章中的业界达人

由社区从 7 条内容中精选。了解更多

Arvind Kushwaha

Head of Quality, Biologics, Dr. Reddy's Laboratories

1 个答复
Dr Nishodh Saxena

Technology Transfer, Quality & Regulatory Oversite at Indian CDMOs, CMOs & CROs for Development, Manufacturing…

1 个答复
Bryan Blair

??LinkedIn Top Voice | Vice President @ GQR

1 Communicate Early

When a delay is anticipated in the biotech manufacturing process, it's crucial to inform stakeholders as soon as possible. Early communication allows for better management of expectations and can prevent the spread of misinformation. By providing stakeholders with updates on what is causing the delay, whether it's a quality control issue, a supply chain bottleneck, or a regulatory hurdle, you enable them to understand the situation fully. This transparency fosters a sense of partnership and shared interest in overcoming the challenges faced.

添加您的观点

Dr Nishodh Saxena

Technology Transfer, Quality & Regulatory Oversite at Indian CDMOs, CMOs & CROs for Development, Manufacturing, Analytical Testing, Storage, and Distribution in the US & EU Markets.
举报内容
Here’s a strategy to help you navigate this: 1. Transparency is Key 2. Regular Updates 3. Detailed Reporting 4. Engage Through Multiple Channels 5. Interactive Q&A Sessions 6. Highlight Progress and Positive Steps 7. Address Concerns Promptly 8. Provide a Roadmap 9. Leverage Visual Aids 10. Personalize Communication 11. Build Relationships 12. Feedback Loop By implementing these strategies, you can maintain stakeholder trust and engagement, even when dealing with the complexities of biotech manufacturing delays.

已翻译

赞
Bryan Blair

??LinkedIn Top Voice | Vice President @ GQR
举报内容
Embracing radical transparency is vital in biotech manufacturing delays. For example, a client faced a significant production setback, and we promptly organized a virtual town hall. However, not all information should be shared immediately. Strategic timing is crucial. Brief delays in communication allow for a thorough understanding and development of potential solutions, maintaining credibility and providing valuable insights. An example is a biotech firm encountering regulatory hurdles. They took a day to consult experts and create a clear action plan before informing stakeholders. This measured approach resulted in a more confident, solution-oriented communication strategy, enhancing trust.

已翻译

赞
Himanshu Jain

Healthcare and Life Sciences Strategy Leader/ Partner |Generative AI HCLS GTM|Einstein Visa Recipient|Business/Digital Transformation | Keynote Speaker| Global Industry Executive
举报内容
Biotech manufacturing is divided in following steps such as preparation, cultivation, fermentation, harvest/purification, final medication, quality control followed by supply chain and distribution including quality control. Following are the key steps to avoid manufacturing delays during each step 1. Early communication is critical on issues across cultivation or quality. Use preventive and predictive maintenance technology 2. Provide constant real time updates through advanced alerts via email, texts and so on. Integrate with sensors 3. Provide clear and succint communication in a simple language and conduct regular stakeholders meetings . Invole shopfloor , business and IT 4. Finalize action plans and create continous improvement

已翻译

赞

加载更多内容

2 Regular Updates

Consistent and regular updates are vital to keeping stakeholders engaged during manufacturing delays. You should establish a routine for sharing progress and setbacks, whether that's through weekly emails, monthly conference calls, or quarterly meetings. This creates a predictable flow of information that stakeholders can rely on, which is especially important when they're making decisions based on the progress of your biotech project. Regular updates also provide an opportunity for stakeholders to offer support or solutions that may help alleviate the delay.

添加您的观点

Bryan Blair

??LinkedIn Top Voice | Vice President @ GQR
举报内容
Proactive communication is key for managing biotech manufacturing delays. As a sales recruiter, I've seen transparent updates turn crises into engagement opportunities. Example: A client's production setback became a virtual town hall, fostering collaboration. However, I believe in strategic timing over immediate disclosure. Brief delays allow for better understanding and solution development, maintaining credibility. Case in point: A biotech firm facing regulatory issues took a day to consult experts before communicating. This led to more confident, solution-oriented messaging, strengthening stakeholder trust.

已翻译

赞

3 Clear Messaging

Clarity in communication is paramount when discussing manufacturing delays with stakeholders. Avoid using jargon or overly technical language that may confuse non-expert stakeholders. Instead, aim to explain the situation in simple terms while still providing enough detail to convey the complexity of the issue. Clear messaging helps ensure that all stakeholders, regardless of their expertise in biotechnology, can follow along and remain informed about the state of manufacturing.

添加您的观点

Arvind Kushwaha

Head of Quality, Biologics, Dr. Reddy's Laboratories
举报内容
I have some reservations about the title. In my view, delays in manufacturing, regardless of the industry, can create challenging situations. It is crucial to keep stakeholders informed and engaged whenever such delays occur. However, biotechnology manufacturing presents a unique scenario due to its reliance on living cells. Despite thorough process characterization, cells may not always behave as expected due to the complexities of protein translation and post-translational modifications. Consequently, uncertainties can arise. Additionally, contamination is an inherent risk. For stakeholders without a biotechnology background, educating them about these uncertainties can help set realistic expectations.

已翻译

赞
Bryan Blair

??LinkedIn Top Voice | Vice President @ GQR
举报内容
A multi-channel communication strategy is crucial for managing biotech manufacturing delays. As a recruiter, I've seen diverse outreach methods boost engagement. For example, we used weekly emails, monthly video calls, and a Slack channel for real-time updates, catering to various preferences. However, strict scheduling isn't always best. Flexibility matters, too. Waiting for planned updates can cause anxiety or speculation. Balancing scheduled and ad hoc communications maintains trust and engagement. Case in point: A biotech startup facing an unexpected regulatory hurdle immediately held a virtual town hall instead of waiting for their monthly update. This proactive approach addressed concerns promptly and fostered collaboration.

已翻译

赞

4 Engage Personally

Personal engagement with stakeholders can significantly enhance trust and understanding during manufacturing delays. Consider setting up one-on-one calls or meetings with key stakeholders to discuss their concerns and provide more detailed explanations. Personalized communication demonstrates your commitment to the relationship and allows for a more nuanced discussion about the challenges and potential solutions. It also gives stakeholders a chance to voice their thoughts directly, which can be invaluable for maintaining strong partnerships.

添加您的观点

5 Action Plans

When informing stakeholders about delays, it's essential to also communicate the action plans in place to address the issues. Detailing the steps being taken to resolve the delay not only shows proactive management but also provides a tangible timeline and set of expectations that stakeholders can monitor. This approach demonstrates accountability and helps instill confidence that the delay is being managed as efficiently as possible.

添加您的观点

6 Feedback Loop

Creating a feedback loop with stakeholders can be an effective way to keep them engaged during manufacturing delays. Encourage stakeholders to share their insights and suggestions for navigating the delay. This not only provides you with potentially valuable information but also gives stakeholders a sense of involvement in the problem-solving process. A feedback loop can foster a collaborative environment where all parties are working together towards a resolution.

添加您的观点

Biotechnology

+ 关注

给文章评分

我们借助人工智能创建了此文章。您认为这篇文章怎么样？

很棒不太好

举报此文章

查看全部

Dealing with biotech manufacturing delays is tough. How can you keep stakeholders informed and engaged?

1

2

3

4

5

6

1 Communicate Early

2 Regular Updates

3 Clear Messaging

4 Engage Personally

5 Action Plans

6 Feedback Loop

Biotechnology

给文章评分

感谢您的反馈

更多Biotechnology相关文章

更多相关阅读内容